AMP-activated protein kinase (AMPK) activation by benzofurans and coumestans isolated from erythrina abyssinica

Phi Hung Nguyen; Thi Ngoc Anh Nguyen; Trong Tuan Dao; Hu Won Kang; Derek Tantoh Ndinteh; Joseph Tanyi Mbafor; Won Keun Oh

doi:10.1021/np900745g

AMP-activated protein kinase (AMPK) activation by benzofurans and coumestans isolated from erythrina abyssinica

Phi Hung Nguyen, Thi Ngoc Anh Nguyen, Trong Tuan Dao, Hu Won Kang, Derek Tantoh Ndinteh, Joseph Tanyi Mbafor, Won Keun Oh

Research output: Contribution to journal › Article › peer-review

42 Citations (Scopus)

Abstract

AMP-activated protein kinase (AMPK) has been proposed as a therapeutic target for the treatment of metabolic syndrome including obesity and type-2 diabetes. The bioassay-guided fractionation of an EtOAc-soluble extract of the stem bark of Erythrina abyssinica led to the isolation of a new coumestan, erythribyssin N (1), and two new benzofurans, erythribyssin F (2) and erythribyssin H (3), along with five known compounds (4-8). When tested for their stimulatory effects on AMPK activity at a concentration of 10 μM, compounds 4 and 5 showed potent activation, while compounds 1, 2, and 7 had moderate effects. These results suggest that benzofurans and coumestans may be new lead compounds for regulating the AMPK enzyme.

Original language	English
Pages (from-to)	598-602
Number of pages	5
Journal	Journal of Natural Products
Volume	73
Issue number	4
DOIs	https://doi.org/10.1021/np900745g
Publication status	Published - 23 Apr 2010
Externally published	Yes

ASJC Scopus subject areas

Analytical Chemistry
Molecular Medicine
Pharmacology
Pharmaceutical Science
Drug Discovery
Complementary and Alternative Medicine
Organic Chemistry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1021/np900745g

Cite this

@article{745c24f631d448379c1c944424014ea8,

title = "AMP-activated protein kinase (AMPK) activation by benzofurans and coumestans isolated from erythrina abyssinica",

abstract = "AMP-activated protein kinase (AMPK) has been proposed as a therapeutic target for the treatment of metabolic syndrome including obesity and type-2 diabetes. The bioassay-guided fractionation of an EtOAc-soluble extract of the stem bark of Erythrina abyssinica led to the isolation of a new coumestan, erythribyssin N (1), and two new benzofurans, erythribyssin F (2) and erythribyssin H (3), along with five known compounds (4-8). When tested for their stimulatory effects on AMPK activity at a concentration of 10 μM, compounds 4 and 5 showed potent activation, while compounds 1, 2, and 7 had moderate effects. These results suggest that benzofurans and coumestans may be new lead compounds for regulating the AMPK enzyme.",

author = "Nguyen, {Phi Hung} and Nguyen, {Thi Ngoc Anh} and Dao, {Trong Tuan} and Kang, {Hu Won} and Ndinteh, {Derek Tantoh} and Mbafor, {Joseph Tanyi} and Oh, {Won Keun}",

year = "2010",

month = apr,

day = "23",

doi = "10.1021/np900745g",

language = "English",

volume = "73",

pages = "598--602",

journal = "Journal of Natural Products",

issn = "0163-3864",

publisher = "American Chemical Society",

number = "4",

}

TY - JOUR

T1 - AMP-activated protein kinase (AMPK) activation by benzofurans and coumestans isolated from erythrina abyssinica

AU - Nguyen, Phi Hung

AU - Nguyen, Thi Ngoc Anh

AU - Dao, Trong Tuan

AU - Kang, Hu Won

AU - Ndinteh, Derek Tantoh

AU - Mbafor, Joseph Tanyi

AU - Oh, Won Keun

PY - 2010/4/23

Y1 - 2010/4/23

N2 - AMP-activated protein kinase (AMPK) has been proposed as a therapeutic target for the treatment of metabolic syndrome including obesity and type-2 diabetes. The bioassay-guided fractionation of an EtOAc-soluble extract of the stem bark of Erythrina abyssinica led to the isolation of a new coumestan, erythribyssin N (1), and two new benzofurans, erythribyssin F (2) and erythribyssin H (3), along with five known compounds (4-8). When tested for their stimulatory effects on AMPK activity at a concentration of 10 μM, compounds 4 and 5 showed potent activation, while compounds 1, 2, and 7 had moderate effects. These results suggest that benzofurans and coumestans may be new lead compounds for regulating the AMPK enzyme.

AB - AMP-activated protein kinase (AMPK) has been proposed as a therapeutic target for the treatment of metabolic syndrome including obesity and type-2 diabetes. The bioassay-guided fractionation of an EtOAc-soluble extract of the stem bark of Erythrina abyssinica led to the isolation of a new coumestan, erythribyssin N (1), and two new benzofurans, erythribyssin F (2) and erythribyssin H (3), along with five known compounds (4-8). When tested for their stimulatory effects on AMPK activity at a concentration of 10 μM, compounds 4 and 5 showed potent activation, while compounds 1, 2, and 7 had moderate effects. These results suggest that benzofurans and coumestans may be new lead compounds for regulating the AMPK enzyme.

UR - http://www.scopus.com/inward/record.url?scp=77951609723&partnerID=8YFLogxK

U2 - 10.1021/np900745g

DO - 10.1021/np900745g

M3 - Article

C2 - 20337486

AN - SCOPUS:77951609723

SN - 0163-3864

VL - 73

SP - 598

EP - 602

JO - Journal of Natural Products

JF - Journal of Natural Products

IS - 4

ER -

AMP-activated protein kinase (AMPK) activation by benzofurans and coumestans isolated from erythrina abyssinica

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this